Format

Send to

Choose Destination
Biochim Biophys Acta. 2000 Oct 18;1482(1-2):298-307.

Lipocalins as biochemical markers of disease.

Author information

1
Department of Medical Sciences, Clinical Chemistry, University of Uppsala, S-751 85 Uppsala, Sweden. shengyuan.xu@medsci.uu.se

Abstract

Lipocalins as biochemical markers of disease have been used extensively. The clinical indications relate to almost any field of medicine, such as inflammatory disease, cancer, lipid disorders, liver and kidney function. Some of the more well-known lipocalins that have been used as markers of disease are orosomucoid, Protein HC (alpha(1)-microglobulin), apolipoprotein D, retinol-binding protein, complement C8 gamma, prostaglandin D synthase and human tear prealbumin, and these markers will be briefly reviewed in this article. Emphasis, however, will be put on the description of another newly described lipocalin, i.e. human neutrophil lipocalin/neutrophil gelatinase-associated lipocalin (HNL/NGAL), since the body fluid measurement of HNL/NGAL was shown to be a superior means to distinguish between acute viral and bacterial infections and also to accurately reflect the activity and involvement of neutrophils in a variety of other diseases.

PMID:
11058770
DOI:
10.1016/s0167-4838(00)00163-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center